Osteoarthritis (OA) is a prevalent degenerative joint disease in dogs, leading to chronic pain, reduced mobility, and a diminished quality of life. Traditional management strategies primarily include pharmaceutical interventions such as nonsteroidal anti-inflammatory drugs (NSAIDs) and physical therapy. However, dietary supplements have emerged as a potential adjunct therapy, offering a promising alternative for managing OA symptoms with fewer side effects. This study evaluates the efficacy of specific dietary supplements in alleviating the symptoms of osteoarthritis in dogs. A cohort of 60 dogs diagnosed with osteoarthritis was selected and divided into two groups: a treatment group receiving a combination of glucosamine, chondroitin sulfate, omega-3 fatty acids, and other joint-supporting nutrients, and a control group receiving a placebo. Over a 12-week period, dogs were monitored for changes in pain levels, mobility, and overall joint function using validated veterinary pain scales, owner assessments, and objective measures such as gait analysis. Results indicated that the treatment group showed a statistically significant improvement in pain reduction and mobility compared to the control group. Specifically, dogs receiving the dietary supplement exhibited enhanced joint flexibility, reduced inflammation, and an overall improvement in quality of life. These findings suggest that dietary supplements can be an effective complementary approach in managing osteoarthritis in dogs, potentially reducing the reliance on NSAIDs and minimizing associated risks. In conclusion, incorporating dietary supplements into the treatment regimen for canine osteoarthritis may offer a safer and effective alternative for improving the well-being of affected dogs. Further long-term studies are recommended to fully understand the benefits and optimal formulations of these supplements in managing osteoarthritis in the canine population.

Canine osteoarthritis, Dietary supplements, Glucosamine

Abdelouahab N. & Heard C. (2008) Effect of the major glycosidesof Harpagophytum procumbens (Devil's Claw) on epidermal cy-clooxygenase-2 (COX-2) in vitro. Journal of Natural Products, 71,746–749.

Abdurhman S.A. (2003) Radiographic osteoarthritis and serum choles-terol. Saudi Medical Journal, 24, 745–747.

Aggarwal B.B. (2007) Signalling pathways of the TNF superfamily: Adouble-edged sword. Immunology 3, 744–756.

Aghazadeh-Habashi A. & Jamali F. (2011) The glucosamine controversy;a pharmacokinetic issue. Journal of Pharmacy and PharmaceuticalSciences, 14, 264–273.

Ahangarpour A., Heidari H., Mard S.A., Hashemitabar M. & KhodadadieA. (2014) Progesterone and cilostazol protect mice pancreatic isletsfrom oxidative stress induced by hydrogen peroxide. Iranian Journalof Pharmaceutical Research, 13, 937–944.

Anderson, K. L., Neill, D. G., Brodbelt, D. C., Churc, D. B., Meeson, R. L.,Sargan, D., Summers, J. F., Zulch, H., & Collins, L. M. (2018). Prevalence,duration and risk factors for appendicular osteoarthritis in a UK dogpopulation under primary veterinary care. Scientific Reports, 8, 5641.

Aragon C.L., Hofmeister E.H. & Budsberg S.C. (2007) Systematic reviewof clinical trials of treatments for osteoarthritis in dogs. Journal of theAmerican Veterinary Medical Association, 230, 514–521.

Barre D.E. (2001) Potential of evening primrose, borage, blackcurrant and fun-gal oils in human health. Annals of Nutrition and Metabolism, 45, 47–57.

Berge, R. K., Ramsvik, M. S., Bohov, P., Svardal, A., Nordrehaug, J. E.,Rosturp, E., Bruheim, I., & Bjørndal, B. (2015). Krill oil reduces plasmatriacylglycerol level and improves related lipoprotein particle concen-tration, fatty acid composition and redox status in healthy young adults- a pilot study. Lipids in Health and Disease, 14, 163.

Bessa Pereira, C., Gomes, P. S., Costa-Rodrigues, J., Almeida Palmas,R., Vieira, L., Ferraz, M. P., Lopes, M. A., & Fernandes, M. H. (2012).